These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32081072)

  • 41. Intra-aortic balloon pump trials: questions, answers, and unresolved issues.
    Perera D; Lumley M; Pijls N; Patel MR
    Circ Cardiovasc Interv; 2013 Jun; 6(3):317-21. PubMed ID: 23780295
    [No Abstract]   [Full Text] [Related]  

  • 42. Revised Heart Allocation Policy Improved Waitlist Mortality and Waiting Time With Maintained Outcomes in En-Bloc Heart-Lung Transplant Candidates and Recipients.
    Shudo Y; He H; Elde S; Woo YJ
    Transpl Int; 2023; 36():11956. PubMed ID: 38152546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient.
    Russo MJ; Jeevanandam V; Stepney J; Merlo A; Johnson EM; Malyala R; Raman J
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):951-5. PubMed ID: 22520721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
    Arias EA; González-Chon O; García-López SM; Chacón MA; Noriega-Iriondo F; Vega RE; Chávez-Tapia NC
    Arch Cardiol Mex; 2005; 75(3):260-6. PubMed ID: 16294814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in waitlist and posttransplant outcomes in patients with adult congenital heart disease after the new heart transplant allocation system.
    Kainuma A; Ning Y; Kurlansky PA; Wang AS; Axom K; Farr M; Sayer G; Uriel N; Naka Y; Takeda K
    Clin Transplant; 2021 Nov; 35(11):e14458. PubMed ID: 34398487
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of mortality in patients with cardiogenic shock treated with primary percutaneous coronary intervention and intra-aortic balloon counterpulsation.
    Schwarz B; Abdel-Wahab M; Robinson DR; Richardt G
    Med Klin Intensivmed Notfmed; 2016 Nov; 111(8):715-722. PubMed ID: 26596273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States.
    Cevasco M; Shin M; Cohen W; Helmers MR; Weingarten N; Rekhtman D; Wald JW; Iyengar A
    Clin Transplant; 2023 Oct; 37(10):e15066. PubMed ID: 37392194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group.
    Rathod KS; Koganti S; Iqbal MB; Jain AK; Kalra SS; Astroulakis Z; Lim P; Rakhit R; Dalby MC; Lockie T; Malik IS; Knight CJ; Whitbread M; Mathur A; Redwood S; MacCarthy PA; Sirker A; O'Mahony C; Wragg A; Jones DA
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):16-27. PubMed ID: 29111770
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.
    Ouweneel DM; Eriksen E; Sjauw KD; van Dongen IM; Hirsch A; Packer EJ; Vis MM; Wykrzykowska JJ; Koch KT; Baan J; de Winter RJ; Piek JJ; Lagrand WK; de Mol BA; Tijssen JG; Henriques JP
    J Am Coll Cardiol; 2017 Jan; 69(3):278-287. PubMed ID: 27810347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
    Cheng JM; den Uil CA; Hoeks SE; van der Ent M; Jewbali LS; van Domburg RT; Serruys PW
    Eur Heart J; 2009 Sep; 30(17):2102-8. PubMed ID: 19617601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock.
    Hernandez-Montfort J; Sinha SS; Thayer KL; Whitehead EH; Pahuja M; Garan AR; Mahr C; Haywood JL; Harwani NM; Schaeffer A; Wencker D; Kanwar M; Vorovich E; Abraham J; Burkhoff D; Kapur NK
    Circ Heart Fail; 2021 May; 14(5):e007924. PubMed ID: 33905259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the 2018 change in US allocation policy on adults with congenital heart disease.
    Ashraf SF; Hess N; Seese L; Kavarana MN; Tedford RJ; Rajab TK; Kilic A
    J Heart Lung Transplant; 2022 Mar; 41(3):373-381. PubMed ID: 34906403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
    Sanborn TA; Sleeper LA; Bates ER; Jacobs AK; Boland J; French JK; Dens J; Dzavik V; Palmeri ST; Webb JG; Goldberger M; Hochman JS
    J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1123-9. PubMed ID: 10985715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intra-aortic balloon counterpulsation in decompensated cardiomyopathy patients: bridge to transplantation or assist device.
    Norkiene I; Ringaitiene D; Rucinskas K; Samalavicius R; Baublys A; Miniauskas S; Sirvydis V
    Interact Cardiovasc Thorac Surg; 2007 Feb; 6(1):66-70. PubMed ID: 17669772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First-Line Support by Intra-Aortic Balloon Pump in Non-Ischaemic Cardiogenic Shock in the Era of Modern Ventricular Assist Devices.
    den Uil CA; Galli G; Jewbali LS; Caliskan K; Manintveld OC; Brugts JJ; van Mieghem NM; Lenzen MJ; Boersma E; Constantinescu AA
    Cardiology; 2017; 138(1):1-8. PubMed ID: 28501864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modern outcomes of heart-lung transplantation: assessing the impact of the updated US allocation system.
    Shin M; Iyengar A; Helmers MR; Kelly JJ; Song C; Rekhtman D; Cevasco M
    Eur J Cardiothorac Surg; 2022 Dec; 63(1):. PubMed ID: 36472453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
    Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical outcomes of bridge-to-bridge therapy with extracorporeal left ventricular assist device for acute myocardial infarction in cardiogenic shock.
    Tokunaga C; Iguchi A; Nakajima H; Chubachi F; Hori Y; Takazawa A; Hayashi J; Asakura T; Yoshitake A
    BMC Cardiovasc Disord; 2022 Feb; 22(1):54. PubMed ID: 35172726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No survival benefit associated with waiting for non-lung donor heart transplants for adult recipients with congenital heart disease.
    Diamant MJ; Fox AL; Modi VA; Joshi AA; Clark DE; Bichell DP; Cedars A; Fowler R; Frischhertz BP; Mazurek JA; Schlendorf KH; Shah AS; Zalawadiya SK; Lindenfeld J; Menachem JN
    Clin Transplant; 2021 May; 35(5):e14266. PubMed ID: 33615562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of mechanical circulatory support on pediatric heart transplant candidates with elevated pulmonary vascular resistance.
    Thangappan K; Morales DLS; Vu Q; Lehenbauer D; Villa C; Wittekind S; Hirsch R; Lorts A; Zafar F
    Artif Organs; 2021 Jan; 45(1):29-37. PubMed ID: 32530089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.